MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/cancers17071227

Медицинская библиотека · Cancers · 2025

A Retrospective Analysis of Ambiguous Spitz Tumors Using Next-Generation Sequencing.

Teufer Mario, Theiler Martin, Lanz Joana, Weibel Lisa, Wagner Ulrich, Levesque Mitchell P, Kamarachev Jivko, Dummer Reinhard, Ramelyte Egle

СтатьяПеревод в очереди

Аннотация

Background

Spitz tumors (STs) are a diverse group of melanocytic lesions that range from benign to malignant. STs pose significant classification challenges due to overlapping histological and immunohistochemical (IHC) features among the STs with different malignant potential. This study aimed to assess the diagnostic value of a melanoma-specific next-generation sequencing (NGS) panel (MelArray) combined with IHC analysis to improve the assessment of diagnostically challenging ST cases.

Methods

Patients with STs and available MelArray results were included in this retrospective analysis. Molecular analysis (genetic alterations, tumor mutational burden (TMB), and copy number variations (CNV)), clinical data (demographics and clinical course), and IHC data (scores for markers such as p16, Ki-67, HMB45, PRAME, and Melan A) were evaluated in conjunction and correlated with patient outcomes.

Results

Atypical Spitz tumors (ASTs, n = 20) predominantly exhibited heterozygous deletions in melanoma-relevant genes, but these were not accompanied by the multiple damaging mutations commonly associated with melanoma. IHC scores were higher in ASTs compared to Spitz nevi (SN, n = 3), suggesting an intermediate biologic potential. SN exhibited minimal genetic alterations and low IHC scores, reflecting a benign profile. Genetic analysis of the Spitz melanoma (SM, n = 1) revealed a distinct molecular profile with damaging mutations affecting the key regulatory pathways involved in tumor progression, along with a high TMB, and an IHC score comparable to ASTs. During a median follow-up of 36 months (range: 6-48 months, n = 23), no recurrences, distant metastases, or tumor-related deaths were observed.

Conclusions

The integration of NGS analysis with the MelArray panel, histology, and immunohistochemistry, enhances the diagnostic accuracy of challenging STs by identifying the genetic alterations linked to malignancy risk. This aids in the detection of high-risk lesions that need a more detailed work-up and more stringent follow-up, and those that will follow a benign course. Larger studies are needed to validate the clinical utility and broader applicability.

Для цитирования: Teufer Mario, Theiler Martin, Lanz Joana, Weibel Lisa, Wagner Ulrich, Levesque Mitchell P, Kamarachev Jivko, Dummer Reinhard, Ramelyte Egle. A Retrospective Analysis of Ambiguous Spitz Tumors Using Next-Generation Sequencing.. Cancers. 2025. DOI: 10.3390/cancers17071227.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.